Lilly signs up to $1.3 billion deal with Superluminal Medicines to develop obesity medicines-March 2024-www.financetom.com

Lilly signs up to $1.3 billion deal with Superluminal Medicines to develop obesity medicines

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Lilly signs up to $1.3 billion deal with Superluminal Medicines to develop obesity medicines

Aug 14, 2025 5:36 AM

Aug 14 (Reuters) - Eli Lilly ( LLY ) has signed a deal

worth up to $1.3 billion with privately held Superluminal

Medicines to discover and develop drugs targeting

cardiometabolic diseases and obesity, Superluminal said on

Thursday.

Previous page： Update: Sanofi to Invest $1.08 Billion Into Three French Drug Manufacturing Sites Next page： Avicanna Announced Results of Study in Patients with Epidermolysis Bullosa

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Update: Sanofi to Invest $1.08 Billion Into Three French Drug Manufacturing Sites

May 13, 2024

08:36 AM EDT, 05/13/2024 (MT Newswires) -- (Updates to include additional details in the second to fourth paragraphs.) Sanofi ( SNY ) said Monday that it will invest more than 1 billion euros ($1.08 billion) into three French drug manufacturing facilities as it ramps up production in its home country. The company said that in Vitry-sur-Seine, it will invest 1...

Avicanna Announced Results of Study in Patients with Epidermolysis Bullosa

May 13, 2024

08:40 AM EDT, 05/13/2024 (MT Newswires) -- Avicanna Inc. ( AVCNF ) , a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products, announced Monday completion of the retrospective observational real-world evidence study using its RHO Phyto branded Ultra CBD Topical Cream on patients with epidermolysis bullosa. A statement noted the retrospective cohort study evaluated the...

Update: UBS Makes Nearly $5 Billion in AT1 Debt Available for Equity Conversion

May 13, 2024

08:39 AM EDT, 05/13/2024 (MT Newswires) -- (Updates with additional information on the AT1 bond in second and third paragraph) UBS (UBS) said Monday that roughly $5 billion worth of Additional Tier 1 bonds have been made available for equity conversion. The decision passed by the bank's shareholders last month takes effect starting May 10. It encompasses four outstanding AT1...

GameStop Shares Surge Pre-Bell After 'Roaring Kitty' Returns

May 13, 2024

08:32 AM EDT, 05/13/2024 (MT Newswires) -- GameStop ( GME ) shares were up nearly 40% in recent Monday premarket activity after Roaring Kitty, the social media persona that sparked a massive stock rally with the videogame retailer in 2021, returned online for the first time in three years. Keith Gill, known as Roaring Kitty on YouTube and DeepF------Value on...